Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
32,500
Employees32,500
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
32,500
Employees32,500

BMY Key Statistics

Market cap
120.97B
Market cap120.97B
Price-Earnings ratio
17.18
Price-Earnings ratio17.18
Dividend yield
4.19%
Dividend yield4.19%
Average volume
16.10M
Average volume16.10M
High today
High today
Low today
Low today
Open price
$58.82
Open price$58.82
Volume
0.00
Volume0.00
52 Week high
$62.89
52 Week high$62.89
52 Week low
$42.52
52 Week low$42.52

Stock Snapshot

The current Bristol-Myers Squibb(BMY) stock price is $59.52, with a market capitalization of 120.97B. The stock trades at a price-to-earnings (P/E) ratio of 17.18 and offers a dividend yield of 4.2%.

On 2026-03-27, Bristol-Myers Squibb(BMY) shares started trading at $58.82, with intraday highs of — and lows of —.

Trading volume for Bristol-Myers Squibb(BMY) stock has reached 0, versus its average volume of 16.1M.

Over the past 52 weeks, Bristol-Myers Squibb(BMY) stock has traded between a high of $62.89 and a low of $42.52.

Over the past 52 weeks, Bristol-Myers Squibb(BMY) stock has traded between a high of $62.89 and a low of $42.52.

BMY News

Simply Wall St 6d
A Look At Bristol Myers Squibb Valuation As Recent Results Shape Growth And Cost Outlook

Bristol-Myers Squibb (BMY) has been drawing attention after recent share price moves, with the stock down over the past week and month but showing a gain in the...

A Look At Bristol Myers Squibb Valuation As Recent Results Shape Growth And Cost Outlook
Benzinga 7d
Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma

• Bristol-Myers Squibb shares are experiencing downward pressure. Why is BMY stock retreating? Hodgkin lymphoma (HL) is a cancer in which multinucleated Reed–S...

Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma

Analyst ratings

59%

of 32 ratings
Buy
37.5%
Hold
59.4%
Sell
3.1%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.